80 results on '"Kordelas L"'
Search Results
2. αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation
3. Lost in Transplantation? Unexpected shift from multipotent to late lymphomyeloid hematopoietic stem and progenitor cells in patients 1 year after hematopoietic stem cell transplantation
4. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease
5. Low soluble programmed cell death protein 1 levels post allogeneic stem cell transplantation predict extended chronic graft-versus-host disease and inferior overall survival
6. HIGH LEVELS OF SOLUBLE HUMAN LEUKOCYTE ANTIGEN G FAVOR TOLERANCE AFTER: PH-P430
7. COMPARISON OF IMMUNOMODULATORY ACTIVITIES OF EXOSOME-ENRICHED FRACTIONS: PH-P081
8. SUCCESSFUL TREATMENT OF THERAPY-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE WITH MESENCHYMAL STEM CELL-DERIVED EXOSOMES: 3D-S18–02
9. CML Relapse after Allogeneic HSCT : Survival, Treatment Efficacy and Prognostic Factors for Outcome
10. Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine
11. GCSF reduces mutated (CD27+) B-cells but increases unmutated naïve (CD27-) B-cells in stem cell donors: P1106
12. Results of a phase II study of haplo-identical haematopoietic cell transplantation in adults using reduced-intensity conditioning and CD3/CD19-depleted grafts: O287
13. Haplo-identical allogeneic haematopoietic cell transplantation in adults using reduced-intensity conditioning and CD3/CD19-depleted grafts: O389
14. Outcome and reconstitution after allogeneic hematopoietic stem cell transplantation in patients with secondary myelofibrosis : a retrospective cohort study
15. BluStar.NRW : a project for typing refugees and migrants as potential blood and stem cell donors
16. Impact of anti-Jurkat anti-thymocyte globuline on long-term outcome of Allogeneic matched unrelated donor hematopoietc cell transplantation in hematologic malignancies : A large single-center comparative analysis
17. Adoptive immunotherapy +/- Ruxolitinib and second allogeneic hematopoietic stem cell transplantation in patients with relapsed Myelofibrosis after allogeneic hematopoietic stem cell transplantation
18. Shift of HIV-Tropism in a HIV-patient with large cell anaplastic T-cell-lymphoma undergoing allogeneic stem cell transplantation from a donor with homozygosity for the CCR5 delta32 mutation
19. Prognostic scoring system for multiple myeloma patients undergoing high-dose therapy with autologous stem cell transplantation
20. Successful Resuscitation of a Patient with Ventricular Fibrillation due to Hypomagnesemia under Cetuximab Therapy
21. Exosomes – From Bench to Bedside
22. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study
23. Erfolgreicher Einsatz eines „In-Hospital-Reanimationsteams” in einem Universitätsklinikum
24. Small interfering RNA against BCR-ABL transcripts sensitize mutated T315I cells to nilotinib
25. Adoptive transfer of donor B lymphocytes: a phase 1/2a study for patients after allogeneic stem cell transplantation.
26. Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study.
27. EASIX-1year and late mortality after allogeneic stem cell transplantation.
28. Independent human mesenchymal stromal cell-derived extracellular vesicle preparations differentially attenuate symptoms in an advanced murine graft-versus-host disease model.
29. Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients.
30. Pre-Transplant Serum Leptin Levels and Relapse of Acute Myeloid Leukemia after Allogeneic Transplantation.
31. Editorial: "The Role of Immune Checkpoint Molecules in Solid and Hematopoietic Stem Cell Transplantation".
32. Low Soluble Programmed Cell Death Protein 1 Levels After Allogeneic Stem Cell Transplantation Predict Moderate or Severe Chronic GvHD and Inferior Overall Survival.
33. Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
34. Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
35. Interleukin-18 and Hematopoietic Recovery after Allogeneic Stem Cell Transplantation.
36. Pre-transplant testosterone and outcome of men after allogeneic stem cell transplantation.
37. EASIX and mortality after allogeneic stem cell transplantation.
38. Optimizing anti-T-lymphocyte globulin dosing to improve long-term outcome after unrelated hematopoietic cell transplantation for hematologic malignancies.
39. Decreased Soluble Human Leukocyte Antigen E Levels in Patients After Allogeneic Hematopoietic Stem Cell Transplantation Are Associated With Severe Acute and Extended Chronic Graft-versus-Host Disease and Inferior Overall Survival.
40. Allogeneic transplantation of peripheral blood stem cell grafts results in a massive decrease of primitive hematopoietic progenitor frequencies in reconstituted bone marrows.
41. Interleukin-18 and outcome after allogeneic stem cell transplantation: A retrospective cohort study.
42. Human multipotent hematopoietic progenitor cell expansion is neither supported in endothelial and endothelial/mesenchymal co-cultures nor in NSG mice.
43. Individual Immune-Modulatory Capabilities of MSC-Derived Extracellular Vesicle (EV) Preparations and Recipient-Dependent Responsiveness.
44. Asymmetric dimethylarginine serum levels are associated with early mortality after allogeneic stem cell transplantation.
45. Rapid Rebound of a Preexisting CXCR4-tropic Human Immunodeficiency Virus Variant After Allogeneic Transplantation With CCR5 Δ32 Homozygous Stem Cells.
46. Elevated soluble human leukocyte antigen G levels in patients after allogeneic stem cell transplantation are associated with less severe acute and chronic graft-versus-host disease.
47. High-dose melphalan-based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute myeloid leukaemia.
48. Clinical potential of mesenchymal stem/stromal cell-derived extracellular vesicles.
49. Pretransplant Vitamin D Deficiency Is Associated With Higher Relapse Rates in Patients Allografted for Myeloid Malignancies.
50. Intestinal T lymphocyte homing is associated with gastric emptying and epithelial barrier function in critically ill: a prospective observational study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.